Career Center

SoMCC Event



Industry Insights: Novartis Institutes for BioMedical Research Postdoctoral Program

Date:   Tuesday, September 21, 2010

Time:   12:00 -1:00 PM (Presentation and Q&A)
1:00-1:30 PM (Informal reception)

Location:   Munzer Auditorium, Beckman Center

Sponsor:   School of Medicine Career Center (SoMCC)

Event details:  

NIBR offers innovative scientists two types of postdoctoral fellowships at global sites in Basel, Switzerland; Cambridge, East Hanover and Emeryville, U.S.; Horsham, U.K.; and Shanghai, China.  The principal goal of this program is to train future leading scientists. We expect that these fellows will acquire academic-style training in NIBR's cutting-edge and fast-paced environment with the resources of a large pharmaceutical company. Fellows are encouraged to work on exploratory projects that may open new areas of research at NIBR and ultimately lead to the discovery of new medicines.
Fellows have their primary mentor at NIBR, and on an informal basis, a mentor at an academic institution, thereby supporting flexibility in the fellows’ future career plans.

This presentation will offer insight into NIBR research strategy, research and postdoc opportunities with an emphasis on our Emeryville campus, perspectives of a current postdoctoral fellow, and an overview of the NIBR Postdoctoral Program and application process.

About the Speaker:
W. Ross Tracey, Ph.D., is an Associate Director in the Education Office of the NIBR, Cambridge, MA, where he supports the management of the Postdoc Program as well as developing and teaching scientific education courses.  Dr. Tracey received his doctorate degree in cardiovascular pharmacology from the University of Western Ontario in 1989, after which he pursued post-doctoral training at U. of Virginia Health Sciences Center.  Dr. Tracey then joined Abbott Laboratories, where he worked with Nobel Laureate Dr. Ferid Murad.  Prior to joining Novartis in 2009, he worked for 14 years at Pfizer Global R&D as a lab head and research project leader for cardiovascular and diabetes drug discovery programs.  He serves on the Executive Steering Committee of the Biochemical Pharmacology Discussion Group of the New York Academy of Sciences, and is a member of the American Society for Pharmacology and Experimental Therapeutics, the American Physiological Society, and the Canadian Society of Pharmacology and Therapeutics.  Dr. Tracey’s research interests have focused on endothelial regulation of vascular function, nitric oxide synthase, and cardioprotection, on which he has published extensively.

Free and open to Stanford ID holders.
Additional information and/or registration:   RSVP required. Space is limited, register online

Footer Links: